Heterozygous deleterious mutations in the DNA RECQL-helicase gene BLM have been associated with an increased risk for breast cancer3, but studies on the role of these mutations in susceptibility to CRC have been conflicting4, 5, 6. The gene discussed is BLM; the disease is colorectal carcinoma.